Allergic rhinitis control: contemporary approaches to evaluation
D. S. Tyufilin,
I. A. Deev,
O. S. Kobyakova,
E. S. Kulikov,
N. A. Tabakaev,
D. A. Vinokurova,
N. A. Kirillova https://doi.org/10.20538/1682-0363-2019-2-262-273
Abstract
Objectives. Allergic rhinitis (AR) is highly prevalent all around the world. It adversely affects the quality of life of patients and leads to the development of bronchial asthma, which determines its high socioeconomic burden. International and Russian authorities establish control of the disease as a primary efficacy end point of allergic rhinitis treatment. Nevertheless, there is no international, standardized, validated tool to assess control of allergic rhinitis. In this regard, this review aims to analyze research on the development of such tools and to provide their comparative analysis.
Review methods. Using PubMed, Web of science and Russian Citation Index database, we searched from 1991 to 2019 with logical combinations of the following key words: “allergic rhinitis control”, “AR control”, “AR questionnaire”. A total of 96 publications were included in the study.
Results. All studies were arranged in chronological order and their main results were described. Questionnaires on the quality of life, tools offered by the clinical guidelines, visual analogue scales, and specialized questionnaires for measuring the control of allergic rhinitis were considered separately. The advantages and disadvantages of these instruments are described.
Conclusion. The evidence based on the quality of the tool to support the use of specialized questionnaires was shown. Many disease control scales have been validated, but have some practical disadvantages asprimary efficacy criteria in clinical practice.
About the Authors
D. S. Tyufilin
Siberian State Medical University (SSMU)
Russian Federation
Tyufilin Denis S., Postgraduate Student, Department of Polyclinic Internal and General Medicine
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Tyufilin Denis S., Postgraduate Student, Department of Polyclinic Internal and General Medicine
2, Moscow Trakt, Tomsk, 634050
I. A. Deev
Siberian State Medical University (SSMU)
Russian Federation
Deev Ivan A., DM, Professor, Department of Pediatrics with a Course in Childhood Diseases of the Department of General Medicine
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Deev Ivan A., DM, Professor, Department of Pediatrics with a Course in Childhood Diseases of the Department of General Medicine
2, Moscow Trakt, Tomsk, 634050
O. S. Kobyakova
Siberian State Medical University (SSMU)
Russian Federation
Kobyakova Olga S., DM, Professor, Head of the Department of General Medicine and Polyclinic Internal
Medicine
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Kobyakova Olga S., DM, Professor, Head of the Department of General Medicine and Polyclinic Internal
Medicine
2, Moscow Trakt, Tomsk, 634050
E. S. Kulikov
Siberian State Medical University (SSMU)
Russian Federation
Kulikov Evgeny S., DM, Associate Professor, Department of General Medicine and Polyclinic Internal Medicine
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Kulikov Evgeny S., DM, Associate Professor, Department of General Medicine and Polyclinic Internal Medicine
2, Moscow Trakt, Tomsk, 634050
N. A. Tabakaev
Siberian State Medical University (SSMU)
Russian Federation
Tabakaev Nikolay A., Postgraduate Student, Department of Phthisiology and Pulmonology
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Tabakaev Nikolay A., Postgraduate Student, Department of Phthisiology and Pulmonology
2, Moscow Trakt, Tomsk, 634050
D. A. Vinokurova
Siberian State Medical University (SSMU)
Russian Federation
Vinokurova Darya A., Assistant, Department of Internal Medicine with a course of Clinical Pharmacology
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Vinokurova Darya A., Assistant, Department of Internal Medicine with a course of Clinical Pharmacology
2, Moscow Trakt, Tomsk, 634050
N. A. Kirillova
Siberian State Medical University (SSMU)
Russian Federation
Kirillova Natalya A., PhD, Associate Professor, Department of General Medical and Polyclinic Internal
Medicine
2, Moscow Trakt, Tomsk, 634050
Russian Federation
Kirillova Natalya A., PhD, Associate Professor, Department of General Medical and Polyclinic Internal
Medicine
2, Moscow Trakt, Tomsk, 634050
References
1. Gupta R., Springston E.E., Warrier M.R., Smith B., Kumar R., Pongracic J., Holl J.L. The prevalence, severity and distribution of childhood food allergy in the United States. Pediatrics. 2011; 128 (1): е9–17. DOI: 10.1542/ped.2011-0204.
2. Pawankar R., Canonica G.W, Holgate S.T., Lockey R.F., Blaiss M.S. WAO white book on allergy: Update 2013. Executive summary. World Allergy Organization (WAO). 2013: 20.
3. Meltzer E.O. Quality of life in adults and children with allergic rhinitis. J. Allergy Clin. Immunol. 2001; 108: 45–53. DOI: 10.1067/mai.2001.115566.
4. Bergeron C., Hamid Q. Relationship between asthma and rhinitis: epidemiologic, pathophysiologic, and therapeutic aspects. Allergy Asthma Clin. Immunol. 2005; 1 (2):81–87. DOI: 10.1186/1710-1492-1-2-81.
5. Global strategy for Asthma Management and Prevention (2018 update). [cited 2019 Mar 27]. URL: https://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/
6. Emad A. Koshak. Classification of asthma according to revised 2006 GINA: Evolution from severity to control. Ann. Thorac. Med. 2007 Apr.–June; 2 (2): 45–46. DOI: 10.4103/1817-1737.32228.
7. Аллергический ринит у детей. Клинические рекомендации Союза педиатров России и Российской ассоциации аллергологов и клинических иммунологов. 2016 г. URL: https://www.pediatr-russia.ru/sites/default/files/file/kr_ar.pdf. (дата обращения: 27.03.2019).
8. Аллергический ринит. Клинические рекомендации Российской ассоциации аллергологов и клинических иммунологов. 2018 г. URL: http://nrcii.ru/docs/2.allergic_rhinitis.pdf. (дата обращения: 27.03.2019).
9. Juniper E.F., Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy. 1991 Jan.; 21 (1):77–83.
10. van Oene C.M., van Reij E.J.F., Sprangers M.A.G., Fokkens W.J. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy. 2007; 62 (12): 1359–1371. DOI: 10.1111/j.1398-9995.2007.01482.x.
11. Juniper E.F., Guyatt G.H., Andersson B., Ferrie P.J. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann. Allergy. 1993; 70 (3): 225–230.
12. Juniper E.F., Thompson A.K., Ferrie P.J., Roberts J.N. Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire. J. Allergy Clin. Immunol. 1999; 104: 364–369. DOI: 10.1016/S0091-6749(99)70380-5.
13. Juniper E.F., Thompson A.K., Ferrie P.J., Roberts J.N. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin. Exp. Allergy. 2000; 30 (1): 132–140. DOI: 10.1046/j.1365-2222.2000.00668.x.
14. Santilli J., Nathan R., Glassheim J., Rockwell W., Gold K. Validation of the rhinitis outcomes questionnaire (ROQ). Ann. Allergy Asthma Immunol. 2001; 86 (2): 222–225. DOI: 10.1016/S1081-1206(10)62695-6.
15. Juniper E.F., Rohrbaugh T., Meltzer E.O. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 2003; 111 (3): 484–490. DOI: 10.1067/mai.2003.137.
16. Piccirillo J.F., Edwards D., Haiduk A., Yonan C., Thawley S.E. Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure. Am. J. Rhinol. 1995; 9: 297–306. DOI: 10.2500/105065895781808711.
17. Anderson E.R., Murphy M.P., Weymuller E.A. Jr. Clinimetric evaluation of the sinonasal outcome test-16. Student research award 1998. Otolaryngol. Head Neck Surg. 1999; 121 (6): 702–707. DOI: 10.1053/hn.1999.v121.a100114.
18. Piccirillo J.F., Merritt M.G. Jr., Richards M.L. Psychometric and clinometric validity of the 20-item sino-nasal outcome test (SNOT-20). Otolaryngol. Head Neck Surg. 2002; 126: 41–47. DOI: 10.1067/mhn.2002.121022.
19. Benninger M.S., Senior B.A. The development of the rhinosinusitis disability index. Arch. Otolaryngol. Head Neck Surg. 1997; 123 (11): 1175–1179. DOI: 10.1001/archotol.1997.01900110025004.
20. Atlas S.J., Metson R.B., Singer D.E., Wu Y.A., Gliklich R.E. Validity of a new health-related quality of life instrument for patients with chronic sinusitis. Laryngoscope. 2005; 115 (5): 846–854. DOI: 10.1097/01.MLG.0000157693.92975.02.
21. Douglas S.A., Marshall A.H., Walshaw D., Robson A.K., Wilson J.A. The development of a general nasal patient inventory. Clin. Otolaryngol. Allied Sci. 2001; 26 (5): 425–429. DOI: 10.1046/j.1365-2273.2001.00497.x.
22. Baiardini I., Pasquali M., Giardini A., Specchia C., Passalacqua G., Venturi S. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy. 2003; 58 (4): 289–294. DOI: 10.1034/j.1398-9995.2003.00079.x.
23. Calderуn M.A., Casale T.B., Demoly P. Validation of patient-reported outcomes for clinical trials in allergic rhinitis: a systematic review. The Journal of Allergy and Clinical Immunology: In Practice. 2019 (in press). DOI: 10.1016/j.jaip.2019.01.015.
24. Braido F., Baiardini I., Stagi E., Scichilone N., Rossi O., Lombardi C., Ridolo E., Gani F., Balestracci S., Girbino G., Senna G. E., Bordo A., Church M.K., Canonica G.W. Rhine asthma patient perspective: a short daily asthma and rhinitis QoL assessment. Allergy. 2012; 67 (11): 1443–1450. DOI: 10.1111/all.12014.
25. AbuRuz S.M., Bulatova N.R., Tawalbeh M.I. Development and validation of the Arabic allergic rhinitis quality of life questionnaire. Saudi Med. J. 2009; 30 (12):1577–1583.
26. Roberts G., Hurley C., Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J. Allergy Clin. Immunol. 2003; 111 (3): 491–497. DOI: 10.1067/mai.2003.138.
27. Valero A., Alonso J., Antepara I., Baro E., Colas C., del Cuvillo A. ESPRINT study group and investigators. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire. Value Health. 2007; 10 (6): 466–477. DOI: 10.1111/j.1524-4733.2007.00202.x.
28. Mavroudi A., Chrysochoou E.A., Boyle R.J., Papastergiopulos A., Karantaglis N., Karagiannidou A. Validation study of the pediatric allergic rhinitis quality of life questionnaire. Asian Pac. J. Allergy Immunol. 2016; 34 (2):159–165. DOI: 10.12932/AP0651.34.2.2016.
29. Juniper E.F., Howland W.C., Roberts N.B., Thompson A.K., King D.R. Measuring quality of life in children with rhinoconjunctivitis. J. Allergy Clin. Immunol. 1998; 101:163–170. DOI: 10.1016/S0091-6749(98)70380-X.
30. Bousquet J., van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7–10 December 1999, Geneva, Switzerland. Allergy. 2002 Sept.; 57 (9): 841–855. DOI:10.1034/j.1398-9995.2002.23625.x.
31. Brozek J.L, Bousquet J., Baena-Cagnani C.E., Bonini S., Canonica G.W., Casale T.B. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J. Allergy Clin. Immunol. 2010; 126 (3): 466–476. DOI:10.1016/j.jaci.2010.06.047.
32. Brożek J.L., Bousquet J., Agache I., Agarwal A., Bachert C., Bosnic-Anticevich S., Chavannes N.H. Allergic rhinitis and its impact on asthma (ARIA) guidelines – 2016 revision. J. Allergy Clin. Immunol. 2017; 140 (4): 950–958. DOI: 10.1016/j.jaci.2017.03.050.
33. Bousquet P.J., Bousquet-Rouanet L., Co Minh H.B., Urbinelli R., Allaert F.A., Demoly P. ARIA (allergic rhinitis and its impact on asthma) classification of allergic rhinitis severity in clinical practice in France. Int. Arch. Allergy Immunol. 2007; 143 (3): 163–169. DOI:10.1159/000099307.
34. Valero A., Ferrer M., Sastre J., Navarro A.M., Monclús L., MartíGuadaсo E., Herdman M., Dávila I., Del Cuvillo A., Colás C., Barу E., Antépara I., Alonso J., Mullol J. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the allergic rhinitis and its impact on asthma severity items. J. Allergy Clin. Immunol. 2007. 120 (2): 359–365. DOI:10.1016/j.jaci.2007.04.006.
35. Nogueira-Silva L., Martins S.V., Cruz-Correia R., Azevedo L.F., Morais-Almeida M., Bugalho-Almeida A., Vaz M., Costa-Pereira A., Fonseca J.A. Control of allergic rhinitis and asthma test – a formal approach to the development of a measuring tool. Respir. Res. 2009; 10: 52. DOI: 10.1186/1465-9921-10-52.
36. Fonseca J.A., Nogueira-Silva L., Morais-Almeida M., Sa-Sousa A., Azevedo L.F., Ferreira J., Branco-Ferreira M., Rodrigues-Alves R., Bugalho-Almeida A., Bousquet J. Control of allergic rhinitis and asthma test (CARAT) can be used to assess individual patients over time. Clin. Transl. Allergy. 2012; 2 (1): 16. DOI: 10.1186/2045-7022-2-16.
37. Fonseca J.A., Nogueira-Silva L., Morais-Almeida M., Azevedo L., Sa-Sousa A., Branco-Ferreira M. Fernandes L., Bousquet J. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010; 65 (8): 1042–1048. DOI: 10.1111/j.1398-9995.2009.02310.x.
38. Borrego L.M., Fonseca J.A., Pereira A.M., Pinto V.R., Linhares D., Morais-Almeida M. Development process and cognitive testing of CARATkids – control of allergic rhinitis and asthma test for children. BMC Pediatrics. 2014; 14 (1): 34. DOI: 10.1186/1471-2431-14-34.
39. Linhares D.V., da Fonseca J., Borrego L.M., Matos Á., Pereira A.M., Sá-Sousa A. Validation of control of allergic rhinitis and asthma test for children (CARATKids) – a prospective multicenter study. Pediatric Allergy and Immunology. 2014; 25 (2): 173–179. DOI: 10.1111/pai.12218.
40. Emons J.A.M., Flokstra B.M.J., de Jong C., van der Molen T., Brand H.K., Arends N., Gerth van Wijk R. Use of the control of allergic rhinitis and asthma test (CARATkids) in children and adolescents: Validation in Dutch. Pediatric Allergy and Immunology. 2016; 28 (2): 185–190. DOI: 10.1111/pai.12678.
41. Gani F., Lombardi C., Barrocu L., Landi M., Ridolo E., Bugiani M., Passalacqua G. The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study.Clinical and Molecular Allergy. 2018; 16 (1): 4. DOI:10.1186/s12948-018-0082-y.
42. Ricardo Pereira P., Lopes C. A cross sectional assessment of allergic rhinitis and asthma control at an immunoallergology outpatient hospital setting using CARAT10 questionnaire. Revista Portuguesa de Pneumologia [in Portuguese]. 2013; 19 (4): 163–167. DOI: 10.1016/j.rppneu.2013.01.004.
43. Jalali M.M., Soleimani R., Alavi Foumani A., Ganjeh Khosravi H. Add-on probiotics in patients with persistent allergic rhinitis: A randomized crossover clinical trial. Laryngoscope. 2019 Feb. (in press). DOI: 10.1002/lary.27858.
44. Nathan R.A., Dalal A.A., Stanford R.H., Meltzer E.O., Schatz M., Derebery J., Mintz M., Thompson M.A., Dibenedetti D.B. Qualitative development of the rhinitis control assessment test (RCAT), an instrument for evaluating rhinitis symptom control. Patient. 2010; 3 (2): 91–99. DOI: 10.2165/11318410-000000000-00000.
45. Schatz M., Meltzer E.O., Nathan R., Derebery M.J., Mintz M., Stanford R.H., Dalal A.A., Silvey M.J., Kosinski M. Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann. Allergy Asthma Immunol. 2010; 104 (2): 118–124. DOI: 10.1016/j.anai.2009.11.063.
46. Novakova S.M., Novakova P.I., Yakovliev P.H., Staevska M.T., Mateva N.G., Dimcheva T.D., Peichev J.L. A tree-year course of house dust mite sublingual immunotherapy appears effective in controlling the symptoms of allergic rhinitis. American Journal of Rhinology & Allergy. 2018; 32 (3): 147–152. DOI:10.1177/1945892418764966.
47. Demoly P., Jankowski R., Chassany O., Bessah Y., Allaert F.A. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin. Exp. Allergy. 2011; 41: 860–868. DOI: 10.1111/j.1365-2222.2011.03734.x.
48. Demoly P., Calderon M.A., Casale T., Scadding G., Annesi-Maesano I., Braun J.-J., Serrano E. Assessment of disease control in allergic rhinitis. Clinical and Translational Allergy. 2013; 3 (1): 7. DOI: 10.1186/2045-7022-3-7.
49. Bousquet P.J., Combescure C., Neukirch F., Klossek J.M., Mйchin H., Daures J.P. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007; 62 (4): 367–372. DOI: 10.1111/j.1398-9995.2006.01276.x.
50. Bousquet P.J., Combescure C., Klossek J.M., Daurиs J.P. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J. Allergy Clin. Immunol. 2009; 123 (6): 1349–1354. DOI: 10.1016/j.jaci.2009.02.033.
51. Bousquet J., Lund V.J., Van Cauwenberge P., Bremard-Oury C., Mounedji N., Stevens M.T. et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy. 2003; 58 (8): 733–741. DOI: 10.1034/j.1398-9995.2003.00076.x.
52. ousquet J., Bodez T., Gehano P., Klossek J.M., Liard F., Neukirch F. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int. Arch. Allergy Immunol. 2009; 150 (1): 75–82. DOI: 10.1159/000210383.
53. Demoly P., Bousquet P.J., Mesbah K., Bousquet J., Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin. Exp. Allergy. 2013; 43 (8): 881–888. DOI: 10.1111/cea.12121.
54. Wang Y., Zhu R., Liu G., Li W., Chen H., Daurиs J.P., Chiriac A.M., Demoly P. Prevalence of uncontrolled allergic rhinitis in Wuhan, China: a prospective cohort study. Am. J. Rhinol. Allergy. 2014; 28 (5): 397–403. DOI: 10.2500/ajra.2014.28.4079.
55. Lourenço O., Calado S., Sá-Sousa A., Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. Journal of Managed Care Pharmacy. 2014; 20 (5): 513–522. DOI: 10.18553/jmcp.2014.20.5.513.
56. Bousquet J., Michel J., Standberg T., Crooks G., Iakovidis I., Gomez M. The European innovation partnership on active and healthy ageing: the European geriatric medicine introduces the EIP on AHA column. Eur. Geriatr. Med. 2014; 5 (6): 361–362. DOI: 10.1016/j.eurger.2014.09.010.
57. Bousquet J., Schunemann H.J., Fonseca J., Samolinski B., Bachert C., Canonica G.W., Casale T., Cruz A., Demoly P., Hellings P., Valiulis A, Wickman M., Zuberbier T., Bosnic-Anticevitch S., Bedbrook A., Bergmann K.C., Caimmi D., Dahl R., Fokkens W.J., Grisle I., Lodrup Carlsen K., Mullol J., Muraro A., Palkonen S., Papadopoulos N. MACVIA-ARIA sentinel Network for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015; 70 (11): 1372–1392. DOI: 10.1111/all.12686.
58. Bousquet J., Schьnemann H.J., Hellings P.W., Arnavielhe S., Bachert C., Bedbrook A., Bergmann K.C., Bosnic-Anticevich S., Brozek J., Calderon M., Canonica G.W., Casale T.B., Chavannes N.H., Cox L., Chrystyn H., Cruz A.A., Dahl R., De Carlo G., Demoly P. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J. Allergy Clin. Immunol. 2016; 138 (2): 367–374: e2. DOI: 10.1016/j.jaci.2016.03.025.
59. Bousquet J., Arnavielhe S., Bedbrook A., Bewick M., Laune D., Mathieu-Dupas E. et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin. Transl. Allergy. 2018; 8 (1): 1–21. DOI:10.1186/s13601-018-0227-6.
60. Bousquet J., Bedbrook A., Czarlewski W., Onorato G.L, Arnavielhe S., Laune D., Mathieu-Dupas E., Fonseca J., Costa E., Lourenзo O., Morais-Almeida M., Todo-Bom A., Illario M., Menditto E., Canonica G.W., Cecchi L. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin. Transl. Allergy. 2019; 9: 16. DOI: 10.1186/s13601-019-0252-0.
Review
For citations:
Tyufilin D.S., Deev I.A., Kobyakova O.S., Kulikov E.S., Tabakaev N.A., Vinokurova D.A., Kirillova N.A. Allergic rhinitis control: contemporary approaches to evaluation. Bulletin of Siberian Medicine. 2019;18(2):262-273. https://doi.org/10.20538/1682-0363-2019-2-262-273
Views:
1098
Email this article 